1. Luteolin-rich fraction from Perilla frutescens seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation via regulation of JAK1/STAT3 pathway: A potential anti-inflammatory compound against inflammation-induced long-COVID
   Sivamoke Dissook et al, 2023, Frontiers in Medicine CrossRef
2. The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury
   Shanshan Huang et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
3. Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease
   Yali Wang et al, 2021, Journal of Healthcare Engineering CrossRef
4. Investigating the expression level of miR-17-3p, miR-101-3p, miR-335-3p, and miR-296-3p in the peripheral blood of patients with acute myocardial infarction
   Alireza Bakhshi et al, 2024, Molecular and Cellular Biochemistry CrossRef
5. Therapeutic Effects of Modified Si-Miao-Yong-An Decoction in the Treatment of Rat Myocardial Ischemia/Reperfusion Injury
   Chen Wang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
6. The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
   Jostein Nordeng et al, 2021, Mediators of Inflammation CrossRef
7. Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects
   P. A. Lebedev et al, 2021, Rational Pharmacotherapy in Cardiology CrossRef
8. Rosuvastatin corrects oxidative stress and inflammation induced by LPS to attenuate cardiac injury by inhibiting the NLRP3/TLR4 pathway
   Guocheng Ren et al, 2021, Canadian Journal of Physiology and Pharmacology CrossRef
9. Sparstolonin B Exerts Therapeutic Effects on Collagen-Induced Arthritis by Inhibiting the NLRP3 Inflammasome and Reducing the Activity of α1,3-Fucosyltransferase
   Yue Sun et al, 2021, Mediators of Inflammation CrossRef